Skip to main content

CORRECTION article

Front. Oncol., 23 June 2020
Sec. Molecular and Cellular Oncology
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.00977

Corrigendum: Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis

This article is a correction to:

  1. Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis

    1. Read original article
\nIngrid Dubois-VedrenneIngrid Dubois-Vedrenne1Olivier De Henau&#x;Olivier De Henau1†Virginie Robert&#x;Virginie Robert1†Francina LangaFrancina Langa2Joaquim JavaryJoaquim Javary1Diana Al DelbanyDiana Al Delbany1Olivier Vosters&#x;Olivier Vosters1†Edgar Angelats-CanalsEdgar Angelats-Canals1Maxime VernimmenMaxime Vernimmen1Souphalone Luangsay,&#x;Souphalone Luangsay1,3†Valrie WittamerValérie Wittamer1Marc Parmentier Marc Parmentier1*
  • 1IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium
  • 2Centre d'Ingénierie Génétique Murine (CIGM), Institut Pasteur, Paris, France
  • 3Ogeda S.A., Gosselies, Belgium

A Corrigendum on
Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis

by Dubois-Vedrenne, I., De Henau, O., Robert, V., Langa, F., Javary, J., Al Delbany, D., et al. (2019). Front. Oncol. 9:1253. doi: 10.3389/fonc.2019.01253

Joaquim Javary was not included as an author in the published article.

The corrected Author Contributions Statement appears below.

Author Contributions

VW and MP designed the study. ID-V, OD, and VR performed most experiments. JJ, DA, MV, OV, EA-C, and SL contributed to experiments. FL generated the K5-chemerin mouse lines. ID-V wrote the initial draft. MP supervised the study, acquired funding, and wrote the final draft. All authors edited the manuscript.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: chemerin, CMKLR1, ChemR23, chemical carcinogenesis, squamous cell carcinoma

Citation: Dubois-Vedrenne I, De Henau O, Robert V, Langa F, Javary J, Al Delbany D, Vosters O, Angelats-Canals E, Vernimmen M, Luangsay S, Wittamer V and Parmentier M (2020) Corrigendum: Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis. Front. Oncol. 10:977. doi: 10.3389/fonc.2020.00977

Received: 15 May 2020; Accepted: 18 May 2020;
Published: 23 June 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Dubois-Vedrenne, De Henau, Robert, Langa, Javary, Al Delbany, Vosters, Angelats-Canals, Vernimmen, Luangsay, Wittamer and Parmentier. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Marc Parmentier, mparment@ulb.ac.be

†Present address: Olivier De Henau, iTeos Therapeutics, Gosselies, Belgium
Virginie Robert, Ambiotis SAS, Toulouse, France
Olivier Vosters, Europe Hospitals, Brussels, Belgium
Souphalone Luangsay, Roche Pharmaceutical Research and Early Development, Basel, Switzerland

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.